Sector Chart Amplia Therapeutics Limited

Stocks

ATX

AU0000023822

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:15 2026-08-28 EDT			5-day change	1st Jan Change
0.1450 ^AUD	-3.33%		-3.33%	-3.33%

08-03	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT
08-03	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
AMPLIA THERAPEUTICS LIMITED	53.4M	-	-	-	-	-
WUXI APPTEC CO., LTD.	69.54B
ARGENX SE	64.97B
WUXI BIOLOGICS (CAYMAN) INC.	26.51B
INSMED INCORPORATED	25.89B					-
BIONTECH SE	25.64B					-